After Fede Álvarez decided against returning to helm the planned Alien: Romulus sequel, a new report reveals that The Death of Robin Hood filmmaker Michael Sarnoski is now in the mix.

Day One” director Michael Sarnoski is reportedly being eyed to helm the “Romulus” follow-up. That’s not a bad choice on 20th Century and Álvarez’s part. “Day One” was a capable prequel, and ...

Add Yahoo as a preferred source to see more of our stories on Google. Marvel Comics is gearing up to introduce one of the darkest Alien comics ever published. Dubbed Alien: King Killer, this new ...

U.S. cancer drug developer Day One Biopharmaceuticals (DAWN) has agreed to be acquired by French pharmaceutical group Servier in an all-cash deal worth nearly $2.5B, according to a statement from the ...

Xbox Game Pass Ultimate has had eight day-one games so far in 2026, and only one of these titles has been good. The majority of them have been average, and a few have been underwhelming. And this run ...

As nonprofit-governed Servier continues to make gains with its IDH-mutant glioma med Voranigo, the drugmaker is wading deeper into the rare oncology arena with a new M&A play. Servier on Friday ...

Chris is a Senior News Writer for Collider. He can be found in an IMAX screen, with his eyes watering and his ears bleeding for his own pleasure. He joined the news team in 2022 and accidentally fell ...

Acquisition positions Servier as a leader in pediatric low-grade glioma and expands its pipeline with programs targeting adult and pediatric cancers with high unmet needs Transaction represents total ...

Day One Biopharmaceuticals Inc. (NASDAQ:DAWN) is one of the 10 Stocks to Watch Right Now. Day One soared to a new three-year high on Friday, as investors gobbled up shares following news that it is ...

"There are no safe zones." When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.

Guns down, thinking caps on.